Signal12, Inc. (Signal12), a clinical-stage ophthalmic pharmaceutical company focused on first-of-a-kind patented technologies that enable existing drugs to act through unique neural pathways, today ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback